Cargando…
VEGF‐C and Mortality in Patients With Suspected or Known Coronary Artery Disease
BACKGROUND: The lymphatic system has been suggested to play an important role in cholesterol metabolism and cardiovascular disease. However, the relationships of vascular endothelial growth factor‐C (VEGF‐C), a central player in lymphangiogenesis, with mortality and cardiovascular events in patients...
Autores principales: | Wada, Hiromichi, Suzuki, Masahiro, Matsuda, Morihiro, Ajiro, Yoichi, Shinozaki, Tsuyoshi, Sakagami, Satoru, Yonezawa, Kazuya, Shimizu, Masatoshi, Funada, Junichi, Takenaka, Takashi, Morita, Yukiko, Nakamura, Toshihiro, Fujimoto, Kazuteru, Matsubara, Hiromi, Kato, Toru, Unoki, Takashi, Takagi, Daisuke, Ura, Shuichi, Wada, Kyohma, Iguchi, Moritake, Masunaga, Nobutoyo, Ishii, Mitsuru, Yamakage, Hajime, Shimatsu, Akira, Kotani, Kazuhiko, Satoh‐Asahara, Noriko, Abe, Mitsuru, Akao, Masaharu, Hasegawa, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404168/ https://www.ncbi.nlm.nih.gov/pubmed/30554564 http://dx.doi.org/10.1161/JAHA.118.010355 |
Ejemplares similares
-
Distinct Characteristics of VEGF‐D and VEGF‐C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2020) -
Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study
por: Wada, Hiromichi, et al.
Publicado: (2020) -
Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED‐J Study
por: Wada, Hiromichi, et al.
Publicado: (2022) -
Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure
por: Iguchi, Moritake, et al.
Publicado: (2021) -
Spontaneous coronary artery dissection in a woman undergoing pseudomenopause therapy with leuprorelin: A case report
por: Doi, Kosuke, et al.
Publicado: (2019)